Isofol Reports Early Tumor Shrinkage in Patients with Colorectal Cancer in Phase 1/2a Open Label Extension Study with arfolitixorin
GOTHENBURG, Sweden, January 17, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced positive results from…
by
We use cookies on our website to improve your navigation by remembering your preferences and repeat visits. Click “Read more” to learn more about the cookies on our website and set your own preference by clicking “Cookie settings”. By clicking “Accept all”, you consent to all use of the cookies. Read MoreCookie settingsAccept all
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Of these cookies, those that are categorized as necessary are stored on your browser because they are essential for our website to function. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. However, opting out of some of these cookies may affect your browsing experience
These cookies are necessary for the website to function properly. These cookies ensure basic functionalities and security features of the website. These cookies do not store any personally identifiable information.
Functional cookies help to perform certain functionalities like sharing website content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics for the number of visitors, bounce rate, traffic source, etc.
Marketing cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
